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Abstract: Binge alcohol consumption among adolescents affects the developing neural networks
underpinning reward and stress processing in the nucleus accumbens (NAc). This study explores in
rats the long-lasting effects of early intermittent exposure to intoxicating alcohol levels at adolescence,
on: (1) the response to natural positive stimuli and inescapable stress; (2) stress-axis functionality;
and (3) dopaminergic and glutamatergic neuroadaptation in the NAc. We also assess the poten-
tial effects of the non-intoxicating phytocannabinoid cannabidiol, to counteract (or reverse) the
development of detrimental consequences of binge-like alcohol exposure. Our results show that
adolescent binge-like alcohol exposure alters the sensitivity to positive stimuli, exerts social and
novelty-triggered anxiety-like behaviour, and passive stress-coping during early and prolonged
withdrawal. In addition, serum corticosterone and hypothalamic and NAc corticotropin-releasing
hormone levels progressively increase during withdrawal. Besides, NAc tyrosine hydroxylase levels
increase at late withdrawal, while the expression of dopamine transporter, D1 and D2 receptors is dy-
namically altered during binge and withdrawal. Furthermore, the expression of markers of excitatory
postsynaptic signaling—PSD95; Homer-1 and -2 and the activity-regulated spine-morphing proteins
Arc, LIM Kinase 1 and FOXP1—increase at late withdrawal. Notably, subchronic cannabidiol, during
withdrawal, attenuates social- and novelty-induced aversion and passive stress-coping and rectifies
the hyper-responsive stress axis and NAc dopamine and glutamate-related neuroplasticity. Overall,
the exposure to binge-like alcohol levels in adolescent rats makes the NAc, during withdrawal, a
locus minoris resistentiae as a result of perturbations in neuroplasticity and in stress-axis homeostasis.
Cannabidiol holds a promising potential for increasing behavioural, neuroendocrine and molecular
resilience against binge-like alcohol harmful effects.
Keywords: binge alcohol drinking; adolescence; nucleus accumbens; cannabidiol
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1. Introduction
Heavy binge drinking is highly prevalent among high-school and college students in
western countries [1]. Compared to adults, adolescents are less responsive to many effects
of alcohol intoxication and withdrawal (motor impairment, sedation hangover, anxiety),
but are more sensitive to positive effects of alcohol like euphoria and the facilitation of social
interaction [2–4]. This combination of sensitivities to alcohol facilitates alcohol drinking
by adolescents at well above binge levels [5], defined by the National Institute on Alcohol
Abuse and Alcoholism as an intake of 4–5 drinks per session producing blood alcohol
concentrations of at least 0.08 g/dL [6]. The mesolimbic dopamine (DA) system, consisting
of the ventral tegmental area (VTA) and the nucleus accumbens (NAc), as well as the
associated limbic structures, is involved in the reward and reinforcing effects of alcohol [7,8].
Alcohol stimulates the DA-ergic mesolimbic system by acutely increasing the firing rate
of VTA DA neurones [9–11] and DA release in the NAc [12–14]. Interestingly, withdrawal
after chronic ethanol exposure decreases VTA cell-firing in the NAc for several days after
removal, inducing a profound disarrangement in the electrophysiological properties and
the anatomic architecture of the synaptic triad in adult rats [15,16]. The accumbal synaptic
triad is thought to allow for DA-mediated gating of cortico-striatal glutamatergic synaptic
transmission [17], playing a regulatory role in spine maintenance and stability in medium
spiny neurones (MSNs), the main population of intrinsic GABAergic neurones. Indeed,
a subtle balance between DA levels and glutamate release critically regulates synaptic
plasticity associated with alcohol abuse and withdrawal [18].
Notably, alcohol may modify the developmental reorganization of the mesocorticolim-
bic system, which is a typical process of adolescence. Specifically, the NAc is a hub where
alcohol interacts with pathways related to affective state control and reward processing,
modifying the trajectories of neurodevelopmental and synaptic remodeling that, in turn,
can impair behavioural responses [19,20]. Indeed, developmental rearrangement during
adolescence results in an imbalance between a weak excitatory cortical control and a su-
persensitive DA-ergic signaling in the mesocorticolimbic pathway [21,22], thus creating a
window of increased vulnerability for excessive alcohol consumption [23]. In detail, the
glutamatergic and DA-ergic asset is dynamic during adolescence, when the density of
NMDA [24] and DA receptors typically increases [25–27], spontaneous firing rates of DA
neurones are higher [28] as well as DA turnover [29], and DA transporter density [30].
Moreover, during adolescence, marked changes occur in brain circuits implicated
in responsiveness to stress and emotional stimuli [31], which are profoundly sensitive
to alcohol exposure [32]. Whereas indisputably adolescents exhibit heightened social
interaction [33], they also display elevated reactivity to discrete stressful cues [34]. This
suggests a potential developmental sensitivity of younger populations to prolonged alcohol
exposure, as suggested by the clinical evidence showing that alcohol-abusing adolescents
exhibit enhanced stress reactivity, anxiety and social avoidance [35].
Similarities have been found between human adolescents and adolescents of various
mammalian species in terms of developmental history and behavioural changes, as well as
neural and hormonal alterations [29,36]. This provides reasonable justification for the use of
animal models for the assessment of anxiety-related behaviour under social circumstances
during adolescence. The social interaction test has been used extensively for the assessment
of social anxiety-like behaviour in laboratory rodents [37]. It was found that reductions in
social preference and/or social investigation may reflect an increase in emotional state that
results in dysfunctional social reward/aversion processing [38,39]. Notably, the response
to novelty and motivated behaviour are strongly interconnected. Hyponeophagia in the
novelty-suppressed feeding test (NSFT) is an example: in this case the inhibition of feeding
is caused by the exposure to a novel arena, and the conflict appears between the anxiogenic
environment and hunger-induced behaviour [40].
The development of lasting negative emotional states following chronic alcohol con-
sumption has been studied for decades in rodents [41]. However, little is known about the
onset of negative affective state and abnormal behavioural reactivity in rats subjected to
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intoxicating alcohol levels every other day, along a paradigm of intermittent binge-like
exposure during adolescence. On this basis, we aimed at assessing social anxiety-like be-
haviour, the response to novelty and the sensitivity to natural positive stimuli, and coping
strategies against inescapable stress, together with corticosterone secretion and hypothala-
mic and extrahypotalamic CRH expression, at different stages of the drinking paradigm:
during binge days (BD), at withdrawal day 1 (WD1) and withdrawal day 10 (WD10).
Moreover, in order to investigate to what extent a disarray of the synaptic triad in the
NAc could play a role in the behaviours observed, on the basis of previous study of this
group [15,16], we assessed: (1) DA signaling, by measuring presynaptic tyrosine hydroxy-
lase (TH) expression and DA transporter (DAT) density by immunofluorescence, D1 and
D2 receptor mRNA in the MSN in the NAc; (2) indices of excitatory postsynaptic dynamics,
through the expression of excitatory scaffold markers (.e., post synaptic density protein
95 (PSD95) and Homer 1 and 2 expression); (3) actin polymerization activity-regulated
spine-morphing proteins (i.e., activity-regulated cytoskeleton-associated protein (Arc), and
Lim Domain Kinase 1 [LIM Kinase 1]); and (4) MSN maturity upgrade by Forkhead box p1
(FOXP1) expression.
Given that recent evidence suggests that nonpsychotropic phytocannabinoid cannabid-
iol (CBD) exerts favorable effects on stress-related conditions [42,43] and addictive be-
haviour [44–47] we assessed if repeated CBD treatment during withdrawal may reverse
the behavioural and molecular alterations induced by intermittent alcohol exposure.
2. Materials and Methods
2.1. Animals
Wistar rats from Envigo (Italy) arrived on postnatal day (PND) 21, were housed in
pairs (unless differently indicated) in standard polycarbonate cages with standard bedding
and maintained at 22 ± 2  C with 55 ± 5% humidity on a 12 h light/dark cycle (lights on
08:00 AM). Laboratory rodent chow (Mucedola, Italy) and tap water were available ad
libitum, apart from overnight food restriction before the novelty suppressed feeding test.
Procedures were approved by the Italian Ministry of Health (1119/2016-PR), in adherence
with the current Italian regulation (D.L. 26/2014) and the European directive (2010/63/EU)
on laboratory animals’ care and use. Every effort was made to minimize the number of
animals used and their suffering.
2.2. Drugs
Alcohol (96%; Carlo Erba Reagenti, Milan, Italy) was dissolved in tap water at 25% v/v.
Cannabidiol (2-[(1R, 6R)-6-Isopropenyl-3-methylcyclohex-2-en-1-yl]-5pentylbenzene-1,3-diol)
(CBD), extracted by the Forensic Laboratory of Biologically Active Substances of the University
of Chemistry and Technology of Prague, Czech Republic (purity (NMR) > 99%) [48], was
dissolved in a vehicle of ethanol (1%), Tween 80 (1%), saline and. immediately afterward,
administered intraperitoneally (i.p.) at the dose of 60 mg/kg [46].
2.3. Binge Alcohol Exposure
Rats were exposed to alcohol in an intermittent binge-like paradigm per os, three
days a week, every other day, during adolescence (PND 35–54, [49]) for a total of nine
exposures. Daily, 25% alcohol was prepared from alcohol 96  (Carlo Erba Reagenti, Italy)
diluted with tap water, and administered at the dosage of 3.5 g/kg [50]. Controls were
given an isovolumetric amount of tap water on the same exposure days. Rats were gently
administered alcohol (or water) by introducing the calculated amount of solution in the
rat’s mouth thought a laboratory pipette. This procedure aimed to decrease the distress
of gavage in adolescent rats and employ the common administration route of alcohol
consumption in humans with accurate dosing [51].
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2.4. Behavioural Procedures
Every effort was made to minimize the number of animals used and their suffering.
Behavioural testing occurred in the three experimental groups at different intervals from
the binge-level alcohol exposure: we tested on binge days, for the group BD (45 min
after the alcohol administration; a novelty suppressed feeding test (NSFT) and sucrose
consumption test (ST) was given after the 8th alcohol administration (PND 51); a social
interaction test (SI) was given after the 9th administration (PND 54); at withdrawal day 1,
for the group WD1, (1 day after the alcohol administration); NSFT and ST were performed,
1 day after the alcohol 8th administration (PND 52); SI was performed 1 day after the 9th
administration (PND 55) and, starting from WD10, was also performed for the group WD10
(NSFT and ST, at PND 64; SI at PND 65) (Figure 1A). In order to minimize the distress of
repeated testing and the exposure to stressful procedures, a second cohort of rats at WD10
was assessed for stress-coping in the modified forced swim test (FST). Testing of the CTRL
rats occurred at PND 64. CBD, or vehicle (ethanol [1%]) and Tween 80 [1%], saline) were
administered during withdrawal on PND 55, 57, 59, 61, 63, thus the last administration
occurred 24 h before behavioural testing All testing procedures were conducted between
9:00 AM and 1:00 PM under dim light (15–20 lux). For tissue collection, rats of the first
cohort were sacrificed after the social interaction test.
2.4.1. Novelty-Suppressed Feeding Test (NSFT)
Rats were food-restricted overnight before testing and, on the test day, they were
habituated to the testing room for 1 h. Under dim light conditions, rats were then placed
into a plastic box 50 ⇥ 50 ⇥ 20 cm with bedding. A single pellet of food was positioned
in the center of the box. Rats were then placed in the corner of the box, and the latency
to eat was scored for as long as 10 min during testing [40]. Rats were then immediately
transferred to their home cage in standard lighting conditions, and their latency to eat
was recorded.
2.4.2. Sucrose-Consumption Test (ST)
Rats were individually housed, and one of their two water bottles was replaced with
a 1% sucrose bottle for 24 h. The bottles were then weighed, and sucrose consumption was
calculated by dividing the weight of sucrose solution consumed by the rat’s body weight
(g/kg) [52].
2.4.3. Social Interaction Test (SI)
The testing apparatus (45 ⇥ 45 ⇥ 30 cm) was partially divided into two equally sized
compartments by a white plexiglass partition, which allowed the movement of the rats
between them [50]. On the test day, rats were taken from their home cage and placed
individually in the testing apparatus for a 2-min habituation. A social partner of the same
age and sex was then introduced for a 10-min test period. Social partners were always
unfamiliar with the experimental animal and were experimentally and drug naive. During
the test session, the behaviour of the rats was recorded by a video camera for later scoring.
The frequency and duration of social investigation, allogrooming, social play and cage
exploration (rearing and moving in the cage) were analysed from video recordings by
a trained experimenter blind to the experimental conditions. Social investigation was
defined as the sniffing of any part of the body of the partner. Social-play scoring included
play fighting, such as pinning, pouching, nape-attacking, and following and chasing,
wherein the experimental animal rapidly pursues the partner. Aggressive behaviour was
not displayed by any of the rats. In addition, the time spent in the empty cage compartment
(nonsocial), and the time spent in the same cage compartment of the social partner (social)
were measured. Social avoidance was calculated by the percentage of time spent in the
nonsocial compartment; in addition, motor behaviour was measured in terms of number
of partition crossings during the 2-min habituation.
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Figure 1. Binge-like alcohol exposure during adolescence disrupts reward/aversion behaviour during withdrawal. (A) Rats
exposed to a binge-like alcohol drinking paradigm during adolescence did not show social behaviour alterations at BD,
whereas they displayed (B) decreased duration of social investigation at WD10, as compared with CTRL (*** p < 0.001)
and BD (ˆˆˆ p < 0.001) and (C) increased social anxiety-like behaviour, in terms of social avoidance %, at WD1 and WD10,
when compared with CTRL (* p < 0.05) (D) in the presence of no difference in the number of line crossings, as a measure of
locomotor activity. In addition, (E) rats exposed to a binge-like alcohol drinking paradigm during adolescence did not show
novelty-induced anxiety-like behaviour in the novelty-suppressed feeding test at BD, since no difference in latency to eat in
the novel arena was measured with respect to CTRL, while, at WD10, they show increased latency to eat when compared
with CTRL (** p < 0.01) and BD (ˆ p < 0.05), who showed no difference in latency to eat in their home cage. On the other
hand, (F) at BD rats showed increased sensitivity to natural reward in the sucrose-preference test as compared with CTRL
rats (*** p < 0.001), which significantly decreased at WD10 (ˆ p < 0.05). (G–I) When tested for coping under forced-swim
stress, Rats exposed a to binge-like alcohol drinking during adolescence showed (G) similar swimming duration as CTRL
rats, however, WD10 rats displayed a passive coping strategy withing the first 5 min of the test, wherein we observed (H)
decreased climbing and (I) increased immobility duration, as compared with the CTRL counterpart. BD: binge day; WD1:
withdrawal day 1; WD10: withdrawal day 10; CTRL: water-exposed control group; NSFT: novelty-suppressed feeding test;
ST: sucrose-consumption test; SI: social-interaction test; FST: forced-swim test. Each bar and each circle represent the mean
of n = 7 rats; error bars indicate SEM.
2.4.4. Forced Swim Test (FST)
The modified forced swim test here employed was previously described in [53]. In
this single-session test, rats were placed individually in clear cylinders (40 cm high, 18 cm
inside diameter) filled with 5–6 L of clean water at 22–23  C, for 15 min. The sessions were
videotaped for subsequent analysis. The 15-min session was divided into three separate
time bins (5 min each), and the durations of swimming, climbing and immobility was
recoded. Swimming behaviour was defined as movement throughout the swim chamber;
climbing behaviour consisted of upward-directed movements of the forepaws along the
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side of the cylinder; immobility was assigned when no additional activity was observed
other than that required to keep the rat’s head above the water. Cumulative scores through
the entire session were kept.
2.5. Tissue Collection
Rats of the first cohort were killed and trunk blood samples were collected in the early
afternoon (1:00–3:00 PM). Serum was prepared according to standard protocols and kept
at  20  C until the time of assay. Brains were rapidly removed to ice and divided into
two sagittal halves by employing a brain matrix. One half was immediately immersed
in cold 4% paraformaldehyde for 24 h fixation at 4  C, while the second half was sliced
into 1 mm-thick coronal sections, on ice, and NAc samples were rapidly dissected. Tissue
samples were flash-frozen in dry ice and stored at  80  C until subsequent analysis. Brain
hemispheres were counterbalanced among experiments.
2.6. Blood Alcohol Concentration Measurements
In order to assess blood alcohol concentration, trunk blood was sampled 1 h after
the last binge alcohol exposure. Blood alcohol concentration was quantified in the serum
by employing a commercially available colorimetric assay kit (STA-620; Cell Biolabs, Inc.,
San Diego, CA, USA) according to the protocol supplied by the manufacturer.
2.7. Corticosterone Determination
Serum corticosterone levels (CORT, ng/mL) were measured using a commercially
available ELISA kit (Demeditec Diagnostics GmbH, Kiel, Germany), according to the
manufacturers’ instructions [54].
2.8. RNA Extraction and qRT-PCR
RNA was isolated using homogenization in Trizol (Invitrogen) followed by chloroform
layer separation. The clear RNA layer was then processed (RNAeasy MicroKit, QIAGEN,
Germantown, MD, USA) and analysed with NanoDrop (ND-1000 Spectrophotometer,
Thermo Scientific, Wilmington, DE, USA). A total of 500 ng of RNA was then reverse
transcribed to cDNA (SuperScript IV Reverse Trascriptase, Invitrogen). cDNA was diluted
to 500 uL, and 3 uL were used for each reaction. The reaction mixture consisted of PowerUp
SYBR Green (Master Mix (2X), Applied Biosystems) (12.5 µL), forward and reverse primers
(2 µL), water (8 µL), and the cDNA template. Samples were then heated to 95  C for 10 min
followed by 40 cycles of 95  C for 15 s, 60  C for 1 min, 95  C for 15 s, 60  C for 30 s
and 95  C for 15 s. Analysis was performed using the delta–delta C(t) method. Primers
employed are indicated in Table 1.
2.9. Immunofluorescence Experiments
Fixed brains were coronally sectioned at a thickness of 35 µm using a microtome
(Campden Instruments, Loughborough, UK). Serial sections were collected through the
rostrocaudal dimensions (every sixth slice) and stored at 4  C in 0.02% sodium azide in
phosphate-buffered saline (PBS) until immunofluorescence staining. Brain sections, includ-
ing the NAc (2.20 mm to 1.60 mm from bregma [55]) or the paraventricular hypothalamic
nucleus (PVN) ( 1.4 mm to  1.9 mm from bregma [55]) were washed in PBS for 30 min
and incubated in blocking solution (3% normal goat or donkey serum + 0.3% Triton X-100
in PBS) for 2 h, at room temperature, under gentle shaking. Sections were then incubated
in primary antibody solution for 24 h at 4  C under gentle shaking (3% normal serum, 0.3%
Tween-20 in PBS), with rat anti-DAT (1:100; Santa Cruz Biotechnology, Dallas, TX, USA);
mouse anti-TH (1:500; Santa Cruz Biotechnology, Dallas, TX, USA) or goat anti-PSD95
(1:1000, Abcam). For CRH immunofluorescent staining, sections were incubated with
sheep corticotropin-releasing hormone antibody (NB110-81721, Novus, USA) at a dilution
of 1:200 for 72 h, at 4  C, under gentle shaking. Sections were washed in PBS for 1 h,
incubated in a secondary antibody solution for 2 h under gentle shaking (goat anti-rat
Biomedicines 2021, 9, 1161 7 of 25
Alexa Fluor 488, 1:400; goat anti-mouse Alexa Fluor 594, 1:400; donkey anti-goat Cy2, 1:400;
donkey anti-sheep Cy3, 1:400, Jackson ImmunoResearch, West Grove, PA, USA). After
1 h washing in PBS, slices were briefly incubated with DAPI (1 mg/mL), mounted onto
a Superfrost® Plus (Thermo Scientific, Fisher Scientific GmbH, Schwerte, Germany) and
coverslipped using Vectashield®‘s HardSet TM Antifade mounting medium. Images were
acquired using an epifluorescence microscope (Meji Techno, Saitama, Japan) and the soft-
ware Deltapix Insight, Smorum, Denmark. Positive immunofluorescence was quantified
for each image as integrated density over threshold using Image J and verified by a trained
experimenter. For each NAc section, the value was calculated as the mean of the core and
shell quantifications [56].
Table 1. Primers employed in qRT-PCR experiments.
Gene Name Primer Sequence
Gapdh GTTTGTGATGGGTGTGAACC (Forward)CTTCTGAGTGGCAGTGATG (Reverse)
Dopamine Receptor 1 ACAGATGCATTGTTGATGAC (Forward)
TGCTAGTACAAATGGAGAGG (Reverse)












LIM Domain Kinase 1
ATGAGGTTGACGCTACTTTGTTG (Forward)
CTACACTCGCAGCACCTGAA (Reverse)
Forkhead Box p1 CACGTGGAAGAATGCAGTGC (Forward)GCCTGTAAAGCTGCATTGAG (Reverse)
2.10. Data Calibration and Statistical Analysis
When data exhibited normality and equal variance, the difference between groups
was determined by employing either one-way, two-way or three-way analysis of vari-
ance (ANOVA), including “binge alcohol exposure” as the between-subject factor, and
“environment” or “session” as the repeated-measure factor, or “CBD treatment” as the
within-subject factor. The Bonferroni post hoc test was employed, when necessary. If data
did not show normal distribution or equal variance, a Kruskal–Wallis ANOVA on ranks
and Dunn’s post hoc test were performed. Data are reported as mean ± SEM. In radar
graph representation, measures were standardized to a common scale by z-transformation
with respect to the reference condition as follows: standardized data = (raw data   aver-
age control group)/standard deviation of the control group. Hence, standardized values
are cantered at zero for the reference group, whereas the mean values for the treatment
group are rescaled relative to this [57]. Principal component analysis (PCA) was used
to examine patterns of intercorrelations between the variables studied in cohort 1 [58].
The principal components produced by the orthogonal linear transformation of PCA are
linear combinations of the original measures, on a new coordinate system, reflecting
independent characteristics or dimensions underlying the correlation matrix [59]. The
first principal component or vector is associated to the largest possible variance, whereas
the second represents most of the remaining variation and so forth, with the first three
components generally explaining most of the variance. The loading-factor value of each
measure indicates its importance for the principal component [59]. In the present study,
principal components that together account for 75% of the total explained variance were
highlighted. Here, the original datasets of each individual rat, containing 20 variables,
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including 7 parameters related to behaviour (social investigation, social play, social anxiety,
locomotor activity, latency to eat in a novel environment and in their home cage, sucrose
consumption), 3 variables related to neuroendocrine stress response (CORT, hypothalamic
and accumbal CRH), 4 variables related to pre- and postsynaptic DA signaling (TH, DAT,
D1R, D2R), 6 markers of postsynaptic MSNs signaling (PSD95, HOM1, HOM2, Arc, LIMK,
FOXP1) were standardized using z-scores and analysed to obtain their correlation matrix
and PCAs as previously described [58]. Statistical analysis was performed using Prism v.
9 (Graphpad) and statistical significance was set at alpha = 0.05.
3. Results
3.1. Alcohol Binging during Adolescence Jeopardizes Affective Behaviour
Adolescent rats were exposed to binge-like alcohol administration in an intermittent
drinking paradigm. In our experimental conditions, when rats were sampled on the last
BD, 1 h after binge alcohol exposure, they displayed a BAC of 193 ± 19 mg/dL, indicat-
ing that binge-like alcohol levels (>80 mg/dL) were reached in this study. The effects of
binge-like alcohol exposure during adolescence on affective behaviour, including the social,
emotional and hedonic dimensions, were evaluated at BD, WD1 and WD10 (Figure 1A).
Our data show that binge-like alcohol exposure during adolescence discretely altered
social behaviour in the modified social interaction test (Figure 1B–D). In particular, we
observed a significant effect on social investigation (F(3,24) = 11.1, p < 0.0001), with a
decrease at WD10 with respect to BD (t = 4.8, p = 0.0004) and CTRL (t = 4.81, p = 0.0003);
no differences were observed in the durations of allogrooming (F(3,24) = 2.30, p = 0.1032),
social play (Kruskal–Wallis test: p = 0.0808) or cage exploration (F(3,24) = 2.13, p = 0.1223)
(Figure 1B). In addition, binge-like alcohol exposure during adolescence increased anxiety-
like behaviour under social circumstances during withdrawal (F(3,24)= 4.56, p = 0.0115).
In particular, we observed a significant increase in the avoidance of the compartment
occupied by a conspecific social partner at WD1 (t = 3.23, df = 24, p = 0.0215) and WD10
(t = 2.89, df = 24, p = 0.0486) with respect to CTRL (Figure 1C). No significant effects on
locomotor activity, in terms of number of barrier crossings, was observed (F(3, 24) = 0.982,
p = 0.4177) (Figure 1D). When rats were assessed in the NSFT, data analysis of their la-
tency to eat, in the novel arena and their home cage, indicates a significant main effect of
binge-like alcohol exposure during adolescence (F(3,48) = 5.75, p = 0.0019), of novel envi-
ronment (F(1,48) = 83.2, p < 0.001) and of the interaction between the two statistical factors
(F(3,48) = 4.65, p = 0.0062). Bonferroni post hoc tests show that latency to eat in the novel
arena, at BD, was not different in comparison with CTRL rats (t = 2.64, df = 48, p = 0.0676).
However, a significant increase was observed at WD1 (t = 3.11, df = 48, p = 0.0187) and
WD10 (t =5.56, df = 48, p < 0.001) with respect to CTRL rats. Moreover, rats at WD10
displayed increased latency to eat in the novel arena with respect to BD (t = 2.92, df = 48,
p = 0.0320). Measures of latency to eat in the home cage showed no differences (p > 0.999)
(Figure 1E). When assessed for their response to a natural reward, rats preferred, in all
instances, the sucrose solution to water. However, while water consumption did not differ
between the groups (CTRL: 4.78 ± 0.40 mL; BD: 5.14 ± 1.15 mL; WD1: 3.85 ± 0.32 mL;
WD10: 5.00 ± 0.70 mL; F(3,24) =0.6378, p = 0.5980), binge-like alcohol exposure during ado-
lescence altered sucrose consumption (Kruskal–Wallis test: p = 0.0016), with a significant
increase at BD as compared with CTRL rats (p = 0.0021), whereas sucrose consumption de-
creased at WD10 with respect to BD (p = 0.0280) (Figure 1F). On the other hand, the analysis
of data from the FST shows that binge-like alcohol exposure during adolescence modified
rat’s stress-coping. When swimming duration across the three-time bins was analysed, a
trend for binge-like alcohol exposure during adolescence was observed (F(1,12) = 3.936,
p = 0.0706) (Figure 1G). In addition, during the first 5-min time bin of the test, WD10 rats
displayed decreased climbing (F(1,12) = 20.52, p = 0.0007; Bonferroni post hoc: t= 8.489,
df = 36.00; p < 0.001) (Figure 1H) and increased immobility (F(1,12) = 8.264, p = 0.0140;
Bonferroni post hoc: t= 2.995 df = 36.00; p = 0.0148) (Figure 1I) with respect to CTRL rats.
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3.2. Binge-like Alcohol Exposure during Adolescence Perturbs the Neuroendocrine Stress Response
Binge-like alcohol exposure during adolescence altered the responsiveness of the
HPA axis, in terms of serum CORT levels (Kruskal–Wallis test p = 0.0002). Indeed, CORT
levels increased during withdrawal, with higher levels at WD1 than at BD (Dunn’s mul-
tiple comparisons test: p = 0.0341), and significantly increased at WD10 when compared
with BD (p = 0.0001) and CTRL rats (p = 0.0416) (Figure 2A). When the neuroendocrine
stress response was assessed in terms of hypothalamic (Figure 2B) and extrahypothala-
mic (Figure 2C) CRH immunofluorescence, we observed that binge-like alcohol exposure
during adolescence increased CRH immunofluorescence in the PVN during withdrawal
(F(3, 24) = 18.5, p < 0.0001). In detail, CRH levels significantly increased at WD10 with
respect to CTRL (t = 5.47, df = 24, p < 0.0001), BD (t = 7.12, df = 24, p < 0.0001) and WD1
(t = 4.39, df = 24, p< 0.0001) (Figure 2D,E). Moreover, Rats exposed a to binge-like alcohol
drinking during adolescence showed altered CRH levels in the NAc (Kruskal–Wallis test:
p < 0.001), where CRH immunostaining was significantly increased at WD1, with respect
to CTRL (Dunn’s post hoc test: p = 0.0133), and at WD10 with respect to CTRL (p < 0.0001)
and BD (p = 0.0054) rats (Figure 2F,G).
3.3. Binging on Alcohol during Adolescence Alters Neuroplasticity in the NAc during Withdrawal
When we examined the effects of binge-like alcohol drinking during adolescence
on DA signaling in the NAc (Figure 3A–F), our data show a significant main effect of
binge-like alcohol exposure on TH-positive immunofluorescence (F(3,24) = 31.3, p < 0.0001),
with increased levels at WD10 in comparison with CTRL (t = 7.87, df = 24, p < 0.0001), BD
(t = 6.72, df = 24, p < 0.001) and WD1 (t = 8.65, df = 24, p < 0.001) (Figure 3B,C). In addition,
data analysis highlights a significant main effect on DAT-positive immunofluorescence
(F(3,24) = 92.0, p < 0.0001), with decreased levels at BD (t = 8.21, df = 24, p < 0.001) and WD1
(t = 4.39, df = 24, p = 0.012) with respect to CTRL rats. On the other hand, DAT-positive
immunofluorescence increased during withdrawal, with higher levels at WD1 than at BD
(t = 3.82, df = 24, p = 0.005), and at WD10 when compared with CTRL (t = 7.59, df = 24,
p < 0.001), BD (t = 15.8, df = 24, p < 0.001) and WD1 (t = 12.0, df = 24, p < 0.001) (Figure 3B,D).
In addition, binge-like alcohol exposure during adolescence modified gene expression
relevant to DA signaling in the NAc. In detail, binge-like alcohol exposure affected D1
receptor expression (F(3,24) = 5.318, p = 0.0059), with increased levels at BD with respect
to CTRL (t = 3.005, df = 24, p = 0.0306) and a significant decrease at WD10 with respect
to BD (t = 3.766, df = 24, p = 0.0047) (Figure 3E). Furthermore, binge-like alcohol during
adolescence modified D2 receptor expression (F(3,24) = 4.279, p = 0.0149), with decreased
levels at BD when compared with the CTRL group (t = 3.088, df = 24, p = 0.0251) and a
significant increase at WD10 with respect to BD (t = 3.004, df = 24, p = 0.0307) (Figure 3F).
On the other hand, binge-like alcohol exposure during adolescence altered postsynaptic
excitatory signaling in the NAc (Figure 4A–H). The analysis of PSD95 immunofluorescence
shows significant differences among the different time points considered (F(3,24) = 5.81,
p = 0.0039), with a significant increase at WD10 when compared with CTRL (t = 4.10,
df = 24, p = 0.0024) (Figure 4A–C). In addition, we observed altered Homer 1 expression
(Kruskal–Wallis test: p = 0.0084), with increased levels at WD10 with respect to BD (Dunn’s
post hoc test: p = 0.0479) and to WD1 (Dunn’s post hoc test: p = 0.009) groups (Figure 4D).
Similarly, Homer 2 expression in the NAc was significantly altered during withdrawal
from binge-like alcohol exposure (Kruskal–Wallis test: p = 0.00187), with increased levels at
WD10 when compared to BD (Dunn’s post hoc test: p = 0.0459) and WD1 (Dunn’s post hoc
test: p = 0.0309) (Figure 4E). Furthermore, we observed significant effects on Arc expression
(Kruskal–Wallis test: p = 0.0047), with increased levels at WD10 with respect to CTRL
(Dunn’s post hoc test: p = 0.0148), BD (p = 0.0376) and WD1 (p = 0.0148) (Figure 4F). As to
LIM Kinase 1 expression, we observed a significant increase at WD10 when compared to
BD (Kruskal–Wallis test: p = 0.0049; Dunn’s post hoc test: p = 0.0086) and WD1 (p = 0.0165)
(Figure 4G). Interestingly, binge-like alcohol exposure during adolescence modified the
expression of FOXP1 (F(3,24) = 104.4, p < 0.001), with decreased levels at WD1 with respect
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to CTRL rats (t = 3.168, df = 24, p = 0.0249), and increased expression at WD10, when
compared with CTRL (t = 12.32, df = 24, p < 0.001), BD (t = 14.77, df = 24, p < 0.001) and
























































































Figure 2. Binge-like alcohol exposure during adolescence perturbs the neuroendocrine stress response during withdrawal.
Rats exposed a to binge-like alcohol drinking paradigm during adolescence (A) did not show corticosterone serum alterations
on BD, whereas they displayed a progressive increase of corticosterone during WD1, when compared with BD (ˆ p < 0.05),
and at WD10, with respect to CTRL (* p < 0.05) and BD (ˆˆˆ p < 0.001). When neuroendocrine stress response was assessed in
terms of (B) hypothalamic and (C) extrahypothalamic CRH immunofluorescence, we found (D,E) a significant increase in
CRH immunofluorescence in the PVN at WD10, when compared with CTRL (*** p < 0.001), BD (ˆˆˆ p < 0.001) and WD1
(   p < 0.01) and (F,G) a significant increase in CRH immunofluorescence in the NAc at WD1, with respect to CTRL rats
(* p < 0.05), and at WD10 with respect to CTRL (*** p < 0.001) and BD (ˆˆ p < 0.01) rats. PVN: paraventricular hypothalamic
nucleus; 3V: third ventricle; NAc: nucleus accumbens; aca anterior commissure. BD: binge day; WD1: withdrawal day 1;
WD10: withdrawal day 10; CTRL: water-exposed control group. Each bar represents the mean of n = 7 rats; error bars
indicate SEM.
3.4. Affective and Emotional Behaviour in Binge-like Alcohol-Exposed Rats Correlates with
Neuroendocrine Stress Response and Transcriptional Alterations in the NAc
Alterations of the neuroendocrine stress response and protein expression at both prsy-
naptic and postsynaptic levels in the NAc may explain abnormal affective end emotional
behaviour occurring in binge-like alcohol-exposed rats. Here we studied the relationship
among 20 variables referring to social, emotional and affective behaviours, neuroendocrine
stress response and markers of neuroplasticity in the NAc, by using PCA. When data from
CTRL, BD, WD1 and WD10 rats were pooled, 67.05% of the overall variance was explained
by the first three components. The main component, corresponding to 44.35% of the vari-
ance, was characterized by 15 of 20 variables on the positive side, with the exception of
social investigation, social play, locomotor activity, sucrose consumption and D1 receptor ex-
pression (Figure 5A). The correlation matrix shows that social investigation was positively
associated with social play (p = 0.019, r = 0.441), and negatively associated with social anxi-
ety (p = 0.004, r =  0.528), latency to eat in the novel environment (p = 0.044, r =  0.383) and
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in the home cage (p = 0.047, r =  0.379), CORT (p = 0.005, r =  0.511), hypothalamic CRH
(p = 0.004, r =  0.523) and accumbal CRH (p < 0.001, r=  0.740), TH (p = 0.014, r =  0.461),
DAT (p = 0.013, r =  0.462), Homer1 (p = 0.015, r =  0.454), Arc (p = 0.006, r =  0.502),
LIM Kinase 1 (p = 0.002, r =  0.556) and FOXP1 (p = 0.0007, r =  0.604). In addition, social
play was positively associated with social investigation (p = 0.019, r = 0.441) and negatively
associated with social anxiety (p = 0.028, r =  0.414) and latency to eat in the novel cage
(p = 0.042, r =  0.387). As for social anxiety, it was positively associated with latency to
eat in the novel arena (p = 0.028, r = 0.415), CRH- (p = 0.003, r = 0.537) and PSD95-positive
immunofluorescence (p = 0.0259, r = 0.420), and FOXP1 expression (p = 0.0474, r = 0.463),
and negatively associated to social investigation (p = 0.004, r=  0.528) and social play
(p = 0.028, r=  0.414). On the other hand, latency to eat in the novel environment was pos-
itively correlated with social anxiety (p = 0.028, r = 0.415), hypothalamic CRH (p = 0.006,
r = 0.507) and accumbal CRH (p = 0.0003, r= 0.634), TH (p = 0.048, r= 0.377), Homer 1
(p = 0.041, r = 0.388), Arc (p = 0.008, r = 0.493), LIMK1 (p = 0.020, r = 0.437) and FOXP1
expression (p = 0.0134, r = 0.462), in a positive trend with CORT (p = 0.067, r = 0.351), and
negatively associated with social investigation (p = 0.044, r=  0.383), social play (p = 0.042,
r=  0.387) and locomotor activity (p = 0.012, r=  0.470). Finally, sucrose consumption was
not correlated with the behavioural variables analysed (p > 0.05), whereas it was positively
associated with D1 receptor expression (p = 0.034, r = 0.403) and negatively associated with
CORT (p = 0.011, r=  0.473), hypothalamic CRH (p = 0.0487, r=  0.376 and accumbal DAT-
positive immunofluorescence (p = 0.0001, r =  0.664), and the expression of the D2 receptor
(p = 0.001, r =  0.594), Homer 1 (p = 0.009, r =  0.484), Homer 2 (p = 0.036, r =  0.397),
Arc (p = 0.028, r =  0.415), LIMK1 (p = 0.007, r =  0.499) and FOXP1 (p = 0.0145, r=  0.457)
(Figure 5B).
3.5. CBD Mitigates Behavioural and Neuroendocrine Dysregulation, and NAc Maladaptive
Neuroplasticity in Binge-Like Alcohol-Exposed Rats
When administered sub-chronically during withdrawal, CBD ameliorated the affective
alterations occurring in rats exposed to binge-like alcohol drinking during adolescence
(Figure 6A,B). The analysis of social investigation in the modified social interaction test
shows a significant effect of binge-like alcohol exposure (F(1,24) = 17.71, p = 0.0003), of
CBD (F(1,24) = 5.574, p = 0.0267) and of the interaction between binge-like alcohol exposure
and CBD (F(1,24) = 17.60, p = 0.0003). As a matter of fact, CBD did not modify social
investigation in CTRL rats (t = 1.297, df = 24, p > 0.999) while it restored the social investi-
gation deficit observed at WD10 (t = 4.636, df = 24.00, p= 0.0006) (Figure 6A). No significant
effect of CBD or interaction was highlighted on data from social play (F(1,24) = 0.1245,
p = 0.7272; F(1,24) = 0.2963, p = 0.5913) and cage exploration (F(1,24) = 0.01546, p = 0.9021;
F(1,24) = 3.864, p = 0.0610). On the other hand, when social avoidance data were anal-
ysed, a significant effect of binge-like alcohol exposure (F(1,24) = 10.13, p = 0.004), CBD
(F(1,24) = 5.896, p = 0.0230) and the rats’ interaction (F(1,24) = 5.364, p = 0.0294) was high-
lighted. CBD treatment did not modify social avoidance in control rats (t = 0.79, df = 24.00,
p > 0.999) whereas it decreased the avoidance of the social compartment in WD10 rats
(t = 3.355, df = 24.00, p = 0.0158) (Figure 6A). No significant effect on exploratory behaviour
was observed (binge: F(1,24) = 2.027, p = 0.1674; CBD:F(1,24)= 4.114, p = 0.0538; interaction:
F(1,24) = 1.110, p = 0.3025) (Figure 6B). In addition, a three-way ANOVA, performed on
latency-to-eat in the novelty-suppressed feeding test, indicates significant main effects of
binge-like alcohol exposure (F(1,48) = 10.3, p = 0.0024), CBD (F(1,48) = 8.14, p = 0.0064),
novel environment (F(1,48) = 43.7, p < 0.0001) and the interactions between novel envi-
ronment and CBD (F(1,48) = 5.63, p = 0.0217), and between the novel environment and
binge-like alcohol exposure (F(1, 48) = 10.3, p = 0.0024). CBD administration did not affect
latency to eat in the novel arena in the CTRL group (t = 1.73, df = 48.00, p > 0.999), while
it significantly decreased latency to eat in the novel arena at WD10 (t = 3.50, df = 48.00,
p = 0.0122) (Figure 6A). The effect of CBD was specific on emotionality, since it did not
affect latency to eat in the home cage (CTRL rats: t = 0.0296, df = 48.00, p > 0.999; WD10
rats: t = 0.509, df = 46.00, p > 0.999). On the other hand, CBD increased rats’ response to
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a natural reward, in terms of sucrose consumption (main effect of CBD: F(1,24)= 46.01,

































































































































Figure 3. Binge-like alcohol exposure during adolescence alters DA signaling in the NAc. Rats exposed to binge-like
alcohol drinking during adolescence show (A–F) altered pre- and postsynaptic markers of DA neurotransmission in the
NAc. In particular, we observed (B,C) increased TH-positive immunofluorescence at WD10, when compared with CTRL
(*** p < 0.001), BD (ˆˆˆ p < 0.001) and WD1 (    p < 0.001); on the other hand, we found (B,D) decreased DAT-positive levels
at BD and WD1, when compared with CTRL (*** p < 0.001; ** p < 0.01), whereas DAT levels increase at WD10, with respect
to CTRL (*** p < 0.001), BD (ˆˆˆ p < 0.001) and WD1 (    p < 0.001) groups. Opposite changes were observed in D1- and
D2R expression levels (E,F). In detail, (E) D1R mRNA relative expression increased at BD with respect to the CTRL group
(* p < 0.05), and decreased during withdrawal, with a significant decrease at WD10 when compared with BD (ˆˆ p < 0.01). On
the other hand, (F) D2R mRNA relative expression significantly decreased at BD when compared with CTRL rats (* p < 0.05)
and significantly increased at WD10, with respect to BD (ˆ p < 0.05). NAc: nucleus accumbens; TH: tyrosine hydroxylase;
DAT: dopamine transporter; D1R: dopamine receptor 1; D2R: dopamine receptor 2; BD: binge day; WD1: withdrawal day
1; WD10: withdrawal day 10; CTRL: water-exposed control group. Each bar represents the mean of n = 7 rats; error bars
indicate SEM. All expression values were normalized to control mean.
When rats were evaluated for coping with the forced swim stress, passive coping
observed at WD10 (binge: F(1,24) = 4.69, p = 0.040) was counteracted by sub-chronic CBD
administration (F(1,24) = 55.5, p < 0.001). In detail, within the first 5 min, WD10 rats showed
increased immobility with respect to CTRL (t = 3.54, df = 72.0, p = 0.046), that was decreased
by CBD (t= 6.54, df = 72.0, p > 0.001) (Figure 6B). While no difference was observed between
CTRL and WD10 rats in the subsequent 5-min time bins (p > 0.999), CBD administration
decreased the duration of immobility in CTRL rats within the second time bin (p < 0.001),
and in WD10 rats during the last time bin (p = 0.002) (Figure 6B).



































































































































Figure 4. Binge-like alcohol exposure during adolescence perturbs post-synaptic excitatory signaling in the NAc. (A–H) Rats
exposed to binge-like alcohol drinking during adolescence show altered levels of post-synaptic markers of glutamate
neurotransmission and activity-regulated proteins at late withdrawal in the NAc. In particular, we observed (B,C) increased
PSD95-positive immunofluorescence at WD10, when compared with CTRL (*** p < 0.001) group; in addition, we found
(D) increased Homer 1 mRNA relative expression at WD10 when compared to BD (ˆ p < 0.05) and WD1 (   p < 0.01), and
(E) increased Homer 2 relative expression at WD10 with respect BD (ˆ p < 0.05) and WD1 (  p < 0.05) groups. Besides this,
(F–H) a significant increase of activity-regulated proteins expression was observed at WD10, as to (F) increased Arc relative
expression at WD10, with respect to CTRL (* p < 0.05), BD (ˆ p < 0.05) and WD1 (  p < 0.05); (G) increased LIM Kinase
1 relative expression at WD10, with respect to BD (p < 0.01) and WD1 (  p < 0.05); (H) increased FOXP1 relative expression
when compared with CTRL (*** p < 0.001), BD (ˆˆˆ p < 0.001) and WD1 (    p < 0.001). NAc: nucleus accumbens; PSD95:
post-synaptic density protein 95; Arc: activity-regulated cytoskeleton-associated protein; LIM Kinase: LIM Kinase 1; BD:
binge day; WD1: withdrawal day 1; WD10: withdrawal day 10; CTRL: water-exposed control group. Each bar represents
the mean of n = 7 rats; error bars indicate SEM. All expression values were normalized to control mean.
As a matter of fact, CBD administration during withdrawal rescued HPA-axis alter-
ations due to binge-like alcohol exposure during adolescence. A two-way ANOVA on
data from serum CORT shows a significant main effect of alcohol binging (F(1,24) = 6.696,
p = 0.0161) and interaction with CBD (F(1,24) = 7.940, p = 0.0095). In detail, we observed
increased serum CORT levels in WD10 rats (vs CTRL: t = 3.822, df = 24, p = 0.0049) that were
significantly decreased by CBD (t = 2.980, df = 24, p = 0.0390) (Figure 6C). Furthermore, CBD
treatment significantly decreased CRH immunopositivity in WD10 rats (F(1, 24)= 40.34,
p < 0.0001) in both the PVN (t = 3.242, df = 24, p = 0.0069) and the NAc (t = 5.740, df = 24,
p < 0.001) (Figure 6C). In addition, CBD sub-chronic administration during withdrawal
counteracted the effects of binge-like alcohol exposure during adolescence on the presy-
naptic markers of DA signaling in the NAc. In particular, CBD decreased TH-positive
immunofluorescence (main effect of binge: F(1,24) = 230.0, p < 0.0001; main effect of CBD:
F(1,24) = 103.9, p < 0.0001) (Figure 6D,G), as well as DAT immunopositivity (main effect of
binge: F(1,24) = 16.79, p = 0.0004; main effect of CBD: F(1,24) = 262.5, p < 0.0001; interaction:
F(1,24) = 50.20, p < 0.0001). In particular, CBD rescued the high DAT levels observed at
WD10 (WD10 vs CTRL: t = 7.907, df = 24, p < 0.001; WD10-CBD Vs WD10: t = 16.47, df = 24,
p < 0.001), with no difference between WD10-CBD and CTRL-CBD levels (t = 2.113, df = 24,
p = 0.2713) (Figure 6E,G). As to PSD95 immunofluorescence, two-way ANOVA indicates
a significant effect of alcohol binging (F(1,24) = 13.65, p = 0.0011), CBD (F(1,24) = 13.07,
p = 0.0014) and their interaction (F(1,24) = 8.259, p = 0.0084). Again, CBD treatment coun-
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teracted the increase in PSD95 levels observed at WD10 (WD10 vs CTRL: t = 4.645, df = 24,
p = 0.0006; WD10 vs WD10 + CBD: t= 4.589, df = 24, p = 0.0007) (Figure 6F,G). The effects
of sub-chronic CBD administration during alcohol withdrawal were also evaluated on
the expression of genes related to DA and glutamate signaling in the NAc. Data analysis
shows that CBD increased the expression of D1R (F(1,24) = 4.481, p = 0.0448) (Figure 6H)
and D2R (F(1,24) = 20.73, p = 0.0001) (Figure 6H). Notably, sub-chronic CBD administration
rescued the effects of binge-like alcohol exposure on Homer 1 expression (F(1,24) = 6.263,
p = 0.0195; interaction with binge-like alcohol exposure: F(1,24) = 11.09, p = 0.0028). In
particular, Homer 1 expression was significantly higher in WD10 rats than in CTRL rats
(t = 3.194, df = 24, p = 0.0234); CBD administration decreased Homer 1 expression in WD10
rats with respect to non-treated counterparts (t = 4.124, df = 24, p = 0.0023), up to CTRL
levels (t = 1.516, df = 24, p = 0.8562), while it did not affect Homer 1 levels in control rats
(t = 0.5849, df = 24, p > 0.999) (Figure 6H). In addition, CBD administration was able to
decrease the expression of Homer 2 (F(1,24) = 4.852, p = 0.0375) (Figure 6H), and compen-
sated the effects of binge-like alcohol exposure during adolescence on Arc expression (main
effect of CBD: F(1,24) = 20.33, p = 0.0001; binge: F(1,24) = 12.09, p = 0.0019; interaction:
F(1, 24) =11.34, p = 0.0026). As a matter of fact, Arc expression was significantly higher at
WD10 than in CTRL rats (t = 4.84, df = 24, p = 0.0004); CBD did not affect Arc expression in
CTRL rats (t = 0.8075, df = 24, p > 0.999) while decreased Arc in WD10 rats, with respect to
vehicle (t = 5.569, df = 24, p < 0.0001), and up to CTRL levels (t = 0.07789, df = 24, p > 0.999)
(Figure 6H). Similarly, CBD administration counteracted the effects of binge-like alcohol
exposure on LIM Kinase 1 expression (main effect of CBD: F(1,24) = 5.529, p = 0.0272; effect
of the interaction between CBD and binge-like alcohol exposure: F(1,24) = 8.749, p = 0.0069).
Indeed, CBD decreased LIM Kinase 1 in WD10 rats (t = 3.754, df = 24, p = 0.0059) and up to
CTRL levels (t = 1.604, df = 24, p = 0.7308), whereas it did not affect LIM Kinase 1 expression
in CTRL rats (t = 0.4288, df = 24, p > 0.999) (Figure 6H). At last, CBD was able to offset the
effects of binge-like alcohol exposure during adolescence on FOXP1 expression (main effect
of CBD: F(1, 24) = 26.13, p < 0.0001; effect of the interaction between CBD and binge-like
alcohol exposure: F(1,24) = 25.81, p < 0.0001). Notably, sub-chronic administration of CBD
decreased FOXP1 expression in WD10 rats (t = 7.207, df = 24.00, p < 0.001), up to CTRL
levels (t = 0.4416, df = 24.00, p > 0.999) and did not modify FOXP1 expression in CTRL rats
(t = 0.02228, df = 24.00, p > 0.999) (Figure 6H).
Figure 5. Affective and emotional behaviours in binge-like alcohol-exposed rats correlate with neuroendocrine stress
response and transcriptional alterations in the NAc. (A) Loading-factor graph of principal component analysis shows how
alterations of neuroendocrine stress response and protein expression at both presynaptic and postsynaptic levels in the NAc
co-variate with affective end emotional behaviour observed in binge-like alcohol-exposed rats during adolescence. (B) The
correlation matrix shows that altered affective and emotional behaviours correlate with neurobiological changes.
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Figure 6. CBD rescues behavioural, neuroendocrine and NAc neuroplasticity maladaptations in binge-like alcohol-exposed
rats. Sub-chronic CBD administration during withdrawal (A) increased social investigation (*** p < 0.001) and decreased
both social avoidance (* p < 0.05) and latency to eat in the novel arena (* p < 0.05) in binge-like alcohol exposed rats;
in addition, it increased sucrose consumption in both WD10 and CTRL rats (*** p < 0.001). Moreover (B) the passive
coping observed at WD10 (* p < 0.05) was counteracted by CBD (ˆˆˆ p < 0.001), which also decreased immobility in CTRL
rats within the second time bin (    p < 0.001) and in WD10 rats during the last time bin (ˆˆ p < 0.01). As for HPA-axis
alterations due to binge-like alcohol exposure during adolescence, (C) CBD decreased serum CORT levels (* p < 0.05) and
CRH immunopositivity in the PVN (** p < 0.01) and the NAc (p < 0.001) in WD10 rats. In addition, CBD was able to
counteract the effects of binge-like alcohol exposure during adolescence on neuroadaptations of DA and glutamate signaling
in the NAc, with reference to (D,G) TH-positive immunofluorescence, (E,G) DAT immunopositivity and (F,G) PSD95
immunofluorescence, and in terms of gene the expression of (H) D1R (+ p < 0.05); D2R (+++ p < 0.001); HOM1 (ˆˆ p < 0.01);
HOM2 (+ p < 0.05); Arc (ˆˆˆ p < 0.001), LIM Kinase 1 (ˆˆ p < 0.01); FOXP1 (ˆˆˆ p < 0.001). CBD: cannabidiol; WD10: withdrawal
day 10; CTRL: water-exposed control group; PVN paraventricular hypothalamic nucleus; NAc: nucleus accumbens; CORT:
corticosterone; CRH: corticotropin releasing hormone; TH: tyrosine hydroxylase; DAT: dopamine transporter; PSD95: post
synaptic density protein 95; D1R: dopamine receptor 1; D2R: dopamine receptor 2; HOM1: Homer 1; HOM2: Homer 2;
Arc: activity regulated cytoskeleton-associated protein; LIM K: LIM domain Kinase 1; FOXP1: Forkhead box P1. Each box
represents the mean (line) and the range values of n = 7 rats; each bar represents the mean of n = 7 rats, and error bars
indicate SEM. Unless differently indicated, boxes and lines in radar graph represent standardized values, cantered at zero
for the CTRL group.
4. Discussion
The repetitive, cyclic pattern of alcohol binge-drinking to intoxication and withdrawal
therefrom is already a trend among adolescents and an important public health concern,
as it is largely agreed that the adolescent brain is particularly sensitive to alcohol-induced
metaplasticity [60]. The main purpose of this research was, then, to highlight a relationship
between a binge-like alcohol exposure in adolescence with alterations in the emotional
state and sensitivity to natural positive stimuli in young adult rats. Our hypothesis is that
excessive, though intermittent, alcohol intake during adolescence may cause prolonged
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disarrangement in neural circuits in the NAc, the motivational and integrational hub of the
mesocorticolimbic system [61].
Our results show that abstinence following binge-like alcohol exposure during ado-
lescence produces an abnormal reactivity to the environmental challenges, displayed
by an increase in anxiety-like behaviour in social- and novel contexts, and impaired re-
ward/aversion processing in adulthood. Several abnormalities occur in stress mediators,
DA signaling, excitatory plasticity and synaptic remodeling that may suggest a hyper-
sensitiveness of the HPA axis and compensatory mechanisms in the NAc. Intriguingly
we found that the administration of CBD, which is known for its potential activity as a
regulator of excitatory and inhibitory tone [43] ameliorates most of the behavioural, cellular
and molecular alterations induced by alcohol exposure and withdrawal in rats, opening a
window towards a putative rescue strategy.
Alcohol produces different outcomes depending on age at exposure (in-utero, adoles-
cence or adulthood) and on time of observation (during intoxication or abstinence_ [52,62–67].
In rodents, adolescence encompasses approximately PND 35 to 55, based on the appearance
of growth spurts, the pruning of excitatory synapses and behavioural characteristics such as
increased peer interaction, play, and exploratory behaviour in the wild (for review see [29]).
Here we exposed PND 35 rats to intermittent alcohol administrations in order to reach intoxi-
cating BAC [6], ruling out intra- and inter-individual variability in alcohol intake, typical of
self-administration paradigms.
Afterwards, we carried out our evaluations during binge days (BD), early (WD1) and
late (WD10) withdrawal. Notably, at these distinct time points, we observed a radical switch
in rat behaviour: if at BD, rats did not display significant differences in their emotional
state in a social context, as compared to controls, at WD1 and WD10 rats displayed social
anxiety-like behaviour, indexed via significant increase in social avoidance and decrease
in social investigation, whereas no alterations occurred in locomotor and explorative
activity. The social interaction test provides a deep insight into emotional behaviour in
laboratory rodents [37]. We employed a modification of the social interaction test, where an
experimental animal can freely move towards or away from the compartment of the arena
of a nonmanipulated social partner. Here, social avoidance reflects anxiety-like behaviour
under social circumstances, as social approach is also directed by motivation [68–70].
Reduced motivational salience associated with natural rewarding stimuli is specifically
reported in social anxiety disorders and substance abuse, suggesting an involvement of
DA-driven reward circuitry [71]. Accordingly, at WD10, rats appeared to suffer from a
higher conflict between the anxiogenic novel environment and hunger-induced behaviour
in the NSFT as shown by an increase in latency to eat with respect to BD and controls. In
this task, rats are challenged by the appeal of a piece of familiar chow in the face of its
location in the middle of a novel open arena. Similar to social aversion, hyponeophagia is
generally considered an anxiety-like feature as shown by several reports on the anxiogenic
effect of alcohol withdrawal in adolescent and adult male rats. Indeed, negative affective
behaviour is observed during abstinence in the NSFT and in the forced swim test [72–74].
Moreover, the “chronic intermittent ethanol vapor exposure model” triggers negative
affective behaviour in male mice in the NSFT after 3 or 5 days of abstinence, and in
the marble-burying test at 2 and 10 days of abstinence [75–77]. Again, due to the dual
component of the rat response—motivation to food and fear of open space—the increase in
latency to eat, here observed in abstinent rats at WD10, can result from the intersection of
altered motivation/aversion processing and abnormal behavioural reactivity, as a measure
of the negative affect stage induced by alcohol withdrawal [78]. On the other hand, when
we assessed sensitivity to positive natural stimuli in a neutral environment, at BD we
measured a greater sucrose consumption compared to basal levels, which progressively
decreased with withdrawal. This result further indicates that natural reward processing is
affected by intermittent exposure to intoxicating alcohol levels and forced abstinence.
Interestingly, late withdrawal interfered with rats’ coping strategies to an inescapable
stress in the FST, a model able to provide a unique insight into the neural limb of the stress
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response [79]. When tested at WD10, rats displayed reduction in climbing and increase in
immobility during the first 5 min in the water, evening out their behaviour akin to controls’
in the following time bins. This behavioural pattern would indicate disruption in coping
strategizing towards adverse environmental conditions, rather than despair, wherein
an adaptive prompt response is required by a sudden change of the environment [80].
Indeed, these results are paralleled by an increase in the stress-system activation during
late withdrawal, as displayed by higher serum CORT levels and hypothalamic CRH levels
at WD10, with respect to controls and BD. Prior work examining the effects of repeated
exposure to alcohol in adolescence on the gene expression of critical regulators of stress
and anxiety likewise reported increased CRH gene expression in the PVN in human
males [81]. On the other hand, in the current experimental model, it seems that the cycle
of intoxicating concentrations of alcohol and its absence every other day did not disrupt
HPA-axis regulation, at least for as long as the intermittent drinking paradigm continues.
Indeed, at WD1 higher serum CORT levels are associated to unmodified CRH expression,
suggesting the maintenance of a regular negative feedback in the hypothalamus. Once
alcohol administration is suspended, an alteration in the balance between HPA drive
and feedback is emphasized, as shown by the concurrent increase in CRH and CORT,
which highlights a hypersensitivity of the brain’s stress response [78]. This result is in
agreement with previous evidence demonstrating that binge-like alcohol exposure during
pubertal development increases both circulating plasma CORT levels and CRH mRNA
expression in the PVN, pointing to the active role played by binge alcohol-drinking in the
disruption of normal glucocorticoid negative feedback pathways [81,82]. CRH expression
is also increased in the NAc, both at WD1 and WD10. Augmented extra-hypothalamic
CRH expression has been correlated with the occurrence of negative affective behaviour
during alcohol withdrawal [78]. Thus, the emotional dysregulation occurring during the
withdrawal days here reported, might result from a between-system—rather than a within-
system—interference, in which CRH may act as a contextual signal, gating the NAc neural
maladaptation associated to binge-like alcohol exposure [83]. Indeed, several reports show
that CRH affects mesolimbic DA-ergic neurones by producing an increase in their functional
state, in terms of DA synthesis, firing, release and reuptake [84,85]; it follows, then, that NAc
DA is involved in the shaping of stress reactivity and motivated behaviour [86,87]. It is not
surprising that the high activity and sensitization of the DA-ergic system occurring during
adolescence may respond dynamically to alcohol stimulation in the repeating cycle of
binging doses and forced abstinence in an intermittent paradigm. When DA signaling and
synaptic plasticity in the NAc are analysed, a profound change in the temporal dynamics
of the components of the striatal DA system is displayed. At BD, if presynaptic DA
synthesis, measured by TH levels, does not differ from controls, the synaptic availability
of the neurotransmitter appears to be increased, since DAT expression decreases. On
the postsynaptic side, a distinguished pattern of expression regards D1 and D2 receptors’
mRNA, with D1R being overexpressed and D2R displaying a significant reduction, as
compared with controls. This peculiar feature would suggest a higher responsivity of
the reward system to positive stimuli, as corroborated by a positive correlation between
sucrose consumption and D1R expression. Indeed, the inhibition of DAT activity by
nomifensine does increase DA availability in the NAc and is reported to increase sucrose
intake, according to a D1R-mediated effect [88,89]. Notably at BD, in accordance with
the behavioural patterns observed in response to social and novel contexts, the indices of
synaptic plasticity taken into consideration in this study do not show significant alterations,
compared with controls.
The intermittence of the binge-like alcohol exposure does not affect DA synthesis,
whereas DAT expression is significantly augmented with respect to BD, producing a relative
reduction in DA synaptic availability at WD1. This evidence is an accordance with several
reports showing a hypo-DAergic input during acute withdrawal after chronic alcohol
exposure [15,16,90]. On the striatal post-synaptic side, we observed a progressive switch
in D1R- and D2R-mRNA expression, with D1R decreasing and D2R increasing during
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withdrawal. Although currently it is not possible to prove a direct causal relationship,
the peculiar dynamics of the striatal components of the DA system may contribute to
the increase in social avoidance observed at WD1; indeed, a reduced DA-ergic input
corresponds to an increase in social avoidance [68]. The framework changes at WD10,
when the increase in DA synthesis is associated with an increase in DA reuptake from
the synaptic cleft, displaying a decrease in D1R and an increase in D2R expression. As
a matter of fact, the primary mechanism controlling the concentration of extracellular
DA is the selective uptake by the high-affinity DA transporter [85], implying that the
increase in DA-ergic synthesis measured at WD10 might not correspond to increased DA
availability in the synaptic cleft. In accordance, our results suggest a limitation in the
duration and strength of the elicited DA-ergic signaling and in the behavioural outcomes of
the event during prolonged abstinence, as shown by an altered response to natural stimuli,
an increase in anxiety-like behaviour, and a dysfunctional coping with stress. Besides,
the reduced D1R- and the increased D2R-expression levels in the NAc indicate that both
receptors are sensitive to perturbation after withdrawal from binge-like alcohol exposure
during adolescence.
Stress-related modifications in limbic synaptic plasticity converge on the NAc as a
significant locus of integration and, in particular, on glutamatergic signaling [91]. Therefore,
it is not unexpected that the hyperactivity of the HPA axis and the NAc over-signaling CRH,
here reported during withdrawal, were associated with altered indices of glutamatergic
transmission. In particular, an increase in the excitatory scaffolding proteins PSD95 and
Homer was measured, indicating an abnormal synaptic strength of glutamate transmission
in the MSNs [92].
Abnormal levels of extracellular glutamate in the NAc have been reported in different
models of binge-like drinking [93–96]. A recent study employing proton magnetic reso-
nance spectroscopy has reported elevated glutamate concentration in the NAc of recently
detoxified patients [97], confirming the plethora of findings from the preclinical models of
alcohol withdrawal [98]. Moreover, recent data show that glutamate synergistic activation
of NMDA and mGLU5 receptors strengthen the synapse-to-nucleus communication via
an increase in the phosphorylation of extracellular signal-regulated protein kinase (ERK),
known as a mediator of inducible gene expression [99]. Interestingly, the integral regula-
tion of ERK is dependent on the cross-talk between NMDA receptor-associated synaptic
adaptor protein PSD95 and the mGluR5-linked adaptor protein Homer [100]. Therefore,
it is evocative to hypothesize that at WD10 the (hyper-)activation of glutamate transmis-
sion is associated with the synergistic over-expression of PSD95 and Homer scaffolding
which, in turn, promote a new asset in the effector systems regulating the expression of
specific markers of synaptic remodeling. Within the NAc, alcohol induces neuroplastic
changes by remodeling dendritic spines [15]. In accordance, we report a selective increase
in players of neuronal activity such as Arc, an immediate early gene that is involved in
neuroplasticity within the soma and dendrites [101], and of cytoskeleton dynamics such as
LIMK1 at late withdrawal [102]. Seminal studies have revealed that NMDAR stimulation
appears necessary for the synthesis and targeting of Arc mRNA to “on-line” synaptic
regions, within dendrites, where stressful conditions can increase Arc expression and lead
to the consolidation of neuroplasticity [103,104]. Therefore, we suggest that the enrichment
in NAc Arc mRNA expression can represent not only a molecular marker of abnormal
excitatory neuroplasticity, but also of social- and novelty-related anxiety-like behaviour
during alcohol withdrawal [105]. LIM Kinase 1 is highly expressed in neurones, where
it regulates actin dynamics. Overexpression of LIM Kinase 1 in cultured cells results in
actin stabilization as filamentous actin, which supports the spine shape and drives the
postsynaptic signaling pathway to maintain spine stability and the dynamic response to
many extracellular cues [102,106].
Overall, the current findings suggest an intersection between modifications in excita-
tory postsynaptic transmission and cytoskeleton-related activity, setting a new architecture
in the MSNs in the NAc. This picture is enriched by the finding of an upregulated expres-
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sion of FOXP1 at WD10 with respect to the other time points of observation. Among the
different transcriptional factors implicated in the development and maturation of neuronal
cells, FOXP1 is particularly abundant in the striatum compared to the rest of the brain [107].
Here it co-localises with markers of MSNs and is tightly controlled by neuronal activity via
synapse-to-nucleus signaling, mediated by NMDAR [108]. To our knowledge, no report
is available on the functional significance of overexpressed FOXP1 in the NAc. However,
based on the current findings, we hypothesize that the overexpression of FOXP1 at WD10
might further affect the maturation of intrinsic excitability of MSNs [109], thus regulating
cellular composition and neurochemical architecture of the striatal circuitry during alcohol
withdrawal metaplasticity [110].
In the attempt to find a sound interpretation of all these pieces and put the puzzle
together, we explored the main axes of variance within the data set by PCA. The analysis
identified the behavioural patterns related to social and environmental anxiety and motiva-
tional processing, and the neuroendocrine parameters and concurrent DA and glutamate
neuroplasticity in the NAc as key variables contributing to the vector that, more than
others, captures the data’s orientation. Interestingly, we observed that the features associ-
ated with sensitivity to positive natural stimuli and D1R expression in the NAc display
an opposite sign with respect to features of anxiety-related behaviours, suggesting an
inverse relationship between them. The divergence of social investigation- and play-related
vectors, with respect to sucrose consumption and D1R expression, suggests the involve-
ment of distinct neural systems in the genesis of the two behavioural dimensions, which
appear discretely affected by binge-like alcohol exposure during adolescence [33,39,111].
In addition, the correlation matrix revealed that the abnormal behavioural response to
social and novel contexts is significantly linked to the intersecting alterations in both stress
response and in pre- and postsynaptic neuroplasticity in the NAc. Interestingly, a signifi-
cant association between FOXP1 expression and all the behavioural readouts produced
by binge-like alcohol exposure in adolescence was highlighted. Although, at this stage,
it is difficult to draw a conclusion, this evidence suggests an intriguing though ventured
perspective, pointing to FOXP1 as a stabilizing factor of the maladaptive synaptic remod-
eling associated with the peculiar behavioural phenotype observed at late withdrawal.
Intriguingly, we also show that metaplasticity, resulting from chronic intermittent-alcohol
withdrawal, is hindered by sub-chronic administrations of CBD. Indeed, CBD was able
to counteract the behavioural alterations induced by late alcohol withdrawal, restored
an adaptive response of the HPA axis, fine-tuned accumbal CRH levels, and discretely
rectified indices of pre-and postsynaptic neuroplasticity. In particular, CBD increased social
investigation and decreased social avoidance, which were not related to changes in motor
activity, since no difference was found in exploratory activity between the experimental
and control groups, in line with previous observations [112,113]. Accordingly, CBD treat-
ment during alcohol withdrawal in rats elicited anxiolytic and pro-active effects in NSFT
and FST, respectively, further supporting CBD’s potential anti-stress properties. This is in
agreement with the anxiolytic-like effect in NSFT and in EPM described by Fogaça and
colleagues [114], which seems to involve a potentiation in endocannabinoid’s signaling
through CB1 receptors [115]. The positive effects of CBD in the FST are confirmed in other
studies, after both acute and chronic treatment at different doses (30-, 100- and 200 mg/kg,
i.p., [116–118]. Furthemore, pretreatment with WAY100635 inhibited CBD effects, suggest-
ing the involvement of 5-HT1A receptors [119]. Adaptive changes in pre- and postsynaptic
5-HT1A receptor functionality were also found after chronic CBD (50 mg/kg/daily/3 days
+ 10 mg/kg/daily/11 days) administration [119].
Besides thes, in our experimental conditions, CBD was able to bring CRH, and CORT
signaling back to control levels. It is already known that CBD, at different doses, decreases
the HPA-axis response under stress condition, as shown by lower CRH mRNA levels in
PVN after 20 min of acute restrain stress [120]. Moreover, CBD reduces cortisol levels and
anxiety in drug-abstinent patients, likely facilitating endocannabinoid signaling on limbic
neural circuits engaged during negative emotional processes [44,121]. On the other hand,
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CBD is reported to modulate reward processing in the mesolimbic system [122], interfering
with DA synthesis and postsynaptic responses [123,124]. In accordance with CBD-induced
reduction in TH gene expression in the VTA of alcohol-drinking rats [47], our data show
lower TH activity, accompanied by decremental levels of DAT immunoreactivity in the NAc,
independently of alcohol exposure. At the same time, a significant increase in D1 and D2R
expression was recorded after CBD treatment, in both WD10 and control rats, suggesting
that the changes at the post-synaptic level aim at restoring DA signaling in the NAc.
Notably, CBD-induced modulation of VTA DA activity may also occur through regulatory
action on glutamatergic projections in the NAc [125]. Consistently, we observed a down
regulation in the expression of the glutamate-associated proteins here analysed, which
suggests a functional remodeling of the postsynaptic side. In this new architecture, it is
compelling to involve even FOXP1 as an index of immature plasticity, which is upregulated
during withdrawal and restored to normal levels by CBD. Indeed, evidence supports the
role of CBD in modulating intracellular pathways directly related to synaptic remodeling.
In particular, a synapse-restoring effect was highlighted in chronically stressed mice, where
repeated CBD treatment promoted an increase in PSD95 expression, synapsyn I/IIi and
synaptophysin [126].
5. Conclusions
Overall, the current evidence evokes a new frame of reference, where, during with-
drawal from binge-like alcohol exposure, an anxiety-prone phenotype, characterized by
an upregulated response to stress plus reduced sensitivity of the reward system, is asso-
ciated with dysfunctional synaptic remodeling, probably via the interplay between the
augmented CRH expression and the limited availability of accumbal DA [127]. In our
opinion, it is unworkable to dissect and consistently interpret all the factors playing in the
CBD-associated remake of the MSN synapse, which is here reported for the first time. The
potential rescue activity of CBD, however, certainly deserves further investigation, also
in the light of the high spread of light cannabis use and the need for scientific evidence
supporting its rationale in pharmacotherapy.
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